Original Article

Journal of Investigative Dermatology (1990) 94, 2s–6s; doi:10.1111/1523-1747.ep12874963

Interleukin-6: Molecular Pathophysiology

Pravinkumar B Sehgal

Rockefeller University, New York, New York, U.S.A.

Top

Abstract

The cytokine interleukin-6 (IL-6) has emerged as a major systemic alarm signal which appears to be produced by essentially every injured tissue. Recent evidence points to the skin, particularly the injured skin, as one of the major sites of IL-6 production. The hallmark of IL-6 gene regulation is its induction by inflammation-associated cytokines, bacterial products, virus infection, and activation of any of the three major signal transduction pathways (diacylglycerol-, cAMP-, and Ca++-activated). Many of these inducers act largely through a 23-bp "multiple-response element" in the IL-6 promoter. Different cell types, including keratinocytes, secrete multiple post-translationally modified forms of IL-6. This cytokine, in turn, plays a key role in activating a variety of local and systemic host defense mechanisms that are aimed at limiting tissue injury. Thus, IL-6 elicits major changes in the biochemical, physiologic, and immunologic status of the host (e.g., the "acute phase" plasma protein response; activation of B, T, and NK-cell function). IL-6 enhances the proliferation of human keratinocytes and of many B-cell lines but inhibits that of certain carcinoma cell lines; nevertheless, IL-6 can enhance the motility of these carcinoma cells. Elevated levels of IL-6 are observed in human body fluids during acute and chronic infections, neoplasia, autoimmune diseases, and psoriasis and following third-degree burns. It is likely that IL-6 produced by cellular elements in the skin represents an important means of communication between the external environment and the millieu interieur.

Top

References

  1. Grossman, RM, Kreuger, J, Yourish, D, Granelli-Piperno, A, Murphy, DP, May, LT, Kupper, TS, Sehgal, PB, Gottlieb, AB: Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989 86: pp 3667–6371,
  2. Sehgal, PB, May, LT, Tamm, I, Vilc caroncek, J: Human beta2 interferon and B-cell differentiation factor BSF-2 are identical. Science 1987 235: 731–732,  | PubMed | ChemPort |
  3. Sehgal, PB, Grieninger, G, Tosato, G: Regulation of the acute phase and immune responses: interleukin-6. Ann NY Acad Sci 1989 557: 1–583,
  4. Sehgal, PB: Interleukin-6: a regulator of plasma protein gene expression in hepatic and non-hepatic tissues. Mol Biol Med (in press)
  5. May, LT, Ghrayeb, J, Santhanam, U, Tatter, SB, Sthoeger, Z, Helfgott, DC, Chiorazzi, N, Grieninger, G, Sehgal, PB: Synthesis and secretion of multiple forms of "beta2-interferon/B-cell differentiation factor BSF-2/hepatocyte stimulating factor" by human fibroblasts and monocytes. J Biol Chem 1988 263: 7760–7766,  | PubMed | ChemPort |
  6. May, LT, Santhanam, U, Tatter, SB, Bhardwaj, N, Ghrayeb, J, Sehgal, PB: Phosphorylation of secreted forms of beta2-interferon/hepatocyte stimulating factor/interleukin-6. Biochem Biophys Res Commun 1988 152: 1144–1150,
  7. Santhanam, U, Ghrayeb, J, Sehgal, PB, May, LT: Post-translational modifications of human interferon-beta2/interleukin-6. Arch Biochem Biophys 1989 274: 161–171,
  8. Helfgott, DC, Tatter, SB, Santhanam, U, Clarick, RH, Bhardwaj, N, May, LT, Sehgal, PB: Multiple forms of IFN-beta/IL-6 in serum and body fluids during acute bacterial infections. J Immunol 1989 142: 948–953,  | PubMed | ChemPort |
  9. Jablons, DM, Mulé, JJ, McIntosh, JK, Sehgal, PB, May, LT, Huang, CM, Rosenberg, SA, Lotze, MT: Interleukin-6/interferon-beta2 as a circulating hormone: induction by cytokine administration in man. J Immunol 1989 142: 1542–1547,
  10. Fong, Y, Moldawer, LL, Marano, M, Wei, H, Tatter, SB, Clarick, RH, Santhanam, U, May, LT, Sehgal, PB, Lowry, SF: Endotoxemia elicits increased circulating beta2-interferon/interleukin-6 in man. J Immunol 1989 142: 2321–2324,  | PubMed | ChemPort |
  11. Nijsten, MW, DeGroot, ER, TenDuis, HJ, Klesen, HJ, Hack, CE, Aarden, LA: Serum levels of interleukin-6 and acute phase responses. Lancet 1989 2: 921,
  12. VanOers, MHJ, Van der Heyden, AAPAM, Aarden, LA: Interleukin-6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 1988 71: 314–319,  | PubMed | ChemPort |
  13. Waage, A, Brandtzaeg, P, Halstensen, A, Kierulf, P, Espevik, T: The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989 169: 333–338,  | Article | PubMed | ISI | ChemPort |
  14. Ritchie, DG, Fuller, GM: Hepatocyte-stimulating factor: a monocyte-derived acute-phase regulatory protein. Ann NY Acad Sci 1983 408: 490–502,
  15. Gauldie, J, Richards, C, Harnish, D, Lansdorp, P, Baumann, H: Interferon-beta2/B cell stimulatory factor 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase response in liver cells. Proc Natl Acad Sci USA 1987 84: 7251–7255,  | Article | PubMed | ChemPort |
  16. Helfgott, DC, May, LT, Sthoeger, Z, Tamm, I, Sehgal, PB: Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta2 interferon in human fibroblasts. J Exp Med 1987 166: 1300–1309,  | Article | PubMed | ChemPort |
  17. Sehgal, PB, Helfgott, DC, Santhanam, U, Tatter, SB, Clarick, RH, Ghrayeb, J, May, LT: Regulation of the acute phase and immune responses in viral disease: enchanced expression of the "beta2-interferon/hepatocyte stimulating factor/interleukin-6" gene in virus-infected human fibroblasts. J Exp Med 1988 167: 1951–1956,
  18. Content, J, DeWit, L, Poupart, P, Opdenakker, G, Van Damme, J, Billiau, A: Induction of a 26-kDa-protein mRNA in human cells treated with interleukin-1-related, leukocyte-derived factor. Eur J Biochem 1985 152: 253–257,  | Article | PubMed | ISI | ChemPort |
  19. Kohase, M, Henriksen-Distefano, D, May, LT, Vilc caronek, J, Sehgal, PB: Induction of beta2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 1986 45: 659–666,  | Article | PubMed | ISI | ChemPort |
  20. Kohase, M, May, LT, Tamm, I, Vilc caronek, J, Sehgal, PB: A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor and interleukin-1. Mol Cell Biol 1987 7: 273–280,  | PubMed | ChemPort |
  21. May, LT, Torcia, G, Cozzolino, F, Ray, A, Tatter, SB, Santhanam, U, Sehgal, PB, Stern, D: Interleukin-6 gene expression in human endothelial cels: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem Biophys Res Commun 1989 159: 991–998,  | Article | PubMed | ChemPort |
  22. Weissenbach, J, Chernajovsky, Y, Zeevi, M, Shulman, L, Soreq, M, Nir, U, Wallach, D, Perricaudet, M, Tiollais, P, Revel, M: Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci USA 1980 77: 7152–7156,
  23. Zilberstein, A, Ruggieri, R, Korn, JH, Revel, M: Structure and expression of cDNA and genes for human interferon-beta-2: a distinct species inducible by growth-stimulatory cytokines. EMBO J 1986 5: 2529–2537,  | PubMed | ISI | ChemPort |
  24. Yasukawa, K, Hirano, T, Watanabe, Y, Muratani, K, Matsuda, T, Nakai, S, Kishimoto, T: Structure and expression of human B cell stimulatory factory-2 (BSF-2/IL-6) gene. EMBO J 1987 6: 2939–2945,  | PubMed | ISI | ChemPort |
  25. Sehgal, PB, Zilberstein, A, Ruggieri, MR, May, LT, Ferguson-Smith, A, Slate, DL, Revel, M, Ruddle, FH: Human chromosome 7 carries the beta2 interferon gene. Proc Natl Acad Sci USA 1986 83: 8957–8961,
  26. Ferguson-Smith, A, Chen, Y-F, Newman, MS, May, LT, Sehgal, PB, Ruddle, FH: Regional localization of the "beta2-interferon/B-cell stimulatory factor 2/hepatocyte stimulating factor" gene to human chromosome 7pl5-p21. Genomics 1988 2: 203–208,
  27. Bowcock, AM, Kidd, JR, Lathrop, M, Daneshvar, L, May, LT, Ray, A, Sehgal, PB, Kidd, KK, Cavalli-Sforza, LL: The human "beta-2 interferon/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 1988 3: 8–16,  | PubMed |
  28. Bowcock, AM, Ray, A, Erlich, H, Sehgal, PB: Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene. Nucl Acid Res 1989 17: 6855–6864,
  29. Ray, A, Tatter, SB, Santhanam, U, Helfgott, DC, May, LT, Sehgal, PB: Regulation of expression of interleukin-6: molecular and clinical studies. Ann NY Acad Sci 1989 557: 353–362,  | PubMed | ChemPort |
  30. Walther, Z, May, LT, Sehgal, PB: Transcriptional regulation of the "beta2-interferon/B-cell differentiation factor BSF-2/hepatocyte stimulating factor HSF" gene in human fibroblasts by other cytokines. J Immunol 1988 140: 974–977,  | PubMed | ChemPort |
  31. Ray, A, Tatter, SB, May, LT, Sehgal, PB: Activation of the human "beta2-interferon/hepatocyte stimulating factor/interleukin-6" promoter by cytokines, viruses and second messengers. Proc Natl Acad Sci USA 1988 85: 6701–6705,
  32. Ray, A, Sassone-Corsi, P, Sehgal, PB: A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation. Mol Cell Biol 1989 9: 5537–5547,  | PubMed | ISI | ChemPort |
  33. Kohase, M, Henriksen-DeStefano, D, Sehgal, PB, Vilc caronek, J: Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin-1 and epidermal growth factor in human fibroblasts. J Cell Physiol 1987 132: 271–278,  | Article | PubMed | ChemPort |
  34. Tabibzadeh, S, Santhanam, U, Sehgal, PB, May, LT: Cytokine-induced production of interferon-beta2/interleukin-6 by freshly-explanted human endometrial stromal cells: modulation by estradiol 17beta. J Immunol 1989 142: 3134–3139,
  35. Hirano, T, Taga, T, Nakano, N, Yasukawa, K, Kashiwamura, S, Shimizu, K, Nakajima, K, Pyun, KH, Kishimoto, T: Purification to homogeneity and characterization of human B cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 1985 82: 5490–5494,  | Article | PubMed | ChemPort |
  36. Bhardwaj, N, Santhanam, U, Lau, LL, Tatter, SB, Ghrayeb, J, Rivelis, M, Steinman, RM, Sehgal, PB, May, LT: Interleukin-6/interferon-beta2 in synovial effusions of patients with rheumatoid arthritis and other arthritides: identification of several isoforms and studies of cellular sources. J Immunol 1989 143: 2153–2159,  | PubMed | ChemPort |
  37. Revel, M, Zilberstein, A, Chen, L, Gothelf, Y, Barash, I, Novick, D, Rubinstein, M, Michaelevicz, R: Biological activities of recombinant human IFN-beta2/IL-6 (E. coli). Ann NY Acad Sci USA 1989 557: 144–156,
  38. Hirano, T, Taga, T, Yamasaki, K, Matsuda, T, Yasukawa, K, Hirata, Y, Yawata, H, Tanabe, O, Akira, S, Kishimoto, T: Molecular cloning of the cDNAs for interleukin-6/B cell stimulatory factor 2 and its receptor. Ann NY Acad Sci 1989 557: 167–180,
  39. Snyers, L, Fontaine, V, Content, J: Modulation of interleukin-6 receptors in human cells. Ann NY Acad Sci 1989 557: 388–393,
  40. Kreuger, JG, Krane, JF, Carter, DM, Gottlieb, AB: Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 94: Suppl 135S–140S,
  41. Yamasaki, K, Taga, T, Hirata, Y, Yawata, H, Kawanishi, Y, Seed, B, Taniguchi, T, Hirano, T, Kishimoto, T: Cloning and expression of the human interleukin-6 (BSF-2/IFNbeta2) receptor. Science 1988 241: 825–828,  | PubMed | ISI | ChemPort |
  42. Taga, T, Hibi, M, Hirata, Y, Yamasaki, K, Yasukawa, K, Matsuda, T, Hirano, T, Kishimoto, T: Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989 58: 573–581,  | Article | PubMed | ISI | ChemPort |
  43. Luger, TA, Schwarz, T, Krutman, J, Kirnbauer, R, Neuner, P, Kock, A, Urbanski, A, Borth, W, Schauer, E: Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells. Ann NY Acad Sci 1989 557: 405–414,
  44. Kupper, TS, Min, K, Sehgal, PB, Mizutani, H, Birchall, N, Ray, A, May, L: Production of IL-6 by keratinocytes: implications for epidermal inflammation and immunity. Ann NY Acad Sci 1989 557: 454–464,  | PubMed | ChemPort |
  45. Tamm, I, Cardinale, I, Kreuger, J, Murphy, JS, May, LT, Sehgal, PB: Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med 1989 170: 1649–1669,

Extra navigation

.
ADVERTISEMENT